SCHEMBL21708794

SCHEMBL21708794

CCCC(F)OC(=O)CCC(CN)c1ccccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 6/20 0.37
CYP1A2 P05177 2/20 0.37
TSHR P16473 3/20 0.36
KCNA5 P22460 2/20 0.35
KCNH2 Q12809 1/20 0.35
CYP2C19 P33261 2/20 0.34
KDM4E B2RXH2 4/20 0.33
CYP3A4 P08684 3/20 0.33
PDE4A P27815 2/20 0.33
MAPT P10636 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
LMNA P02545 2/20 0.33
ABCB11 O95342 1/20 0.33
ESR1 P03372 1/20 0.33
ADRA2A P08913 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708665 0.89 GAA (0.38) GAASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL21708690 0.81 SMN1; SMN2 (0.47) GAASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL21708785 0.79 ROCK2 (0.32) GAAALDH1A1ESR1SLC6A3PTGFR
SCHEMBL21708658 0.79 TAS1R3 (0.34) GAAMEN1KMT2AALDH1A1CYP3A4
SCHEMBL21656127 0.78 CYP2C19 (0.41) GAASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL21510400 0.78 TSHR (0.51) GAASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL21708590 0.78 L3MBTL1 (0.41) MEN1KMT2ATSHRKDM4ETDP1
SCHEMBL21708509 0.78 NISCH (0.36) GAAMEN1KMT2AALDH1A1KDM4E
SCHEMBL21708613 0.77 TAS1R3 (0.33) PTGFR
SCHEMBL21632347 0.76 GABBR2 (0.44) SMN1; SMN2ALDH1A1CYP1A2TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed